Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Public ClinicalTrials.gov record NCT02475629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Single Arm, 24-Week, Multicenter Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant HIV-1
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 3, single arm, multicenter study will evaluate the safety and effectiveness of ibalizumab in treatment-experienced patients infected with multi-drug resistant HIV-1.
Study identification
- NCT ID
- NCT02475629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2015 (Type not available)
- Primary completion
- Oct 2016 (Actual)
- Completion
- Dec 2016 (Actual)
- Last update posted
- Mar 19, 2020
2015 – 2016
United States locations
- U.S. sites
- 27
- U.S. states
- 10
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Long Beach Education and Research Consultants | Long Beach | California | 90813 | — |
| W King Health Care Group | Los Angeles | California | 90008 | — |
| Southern California Permanente Medical Group | Los Angeles | California | 90027 | — |
| Ruane Medical and Clinical Research Institute | Los Angeles | California | 90036 | — |
| Charles R. Drew Univ. of Med. & Science Clinical and Translational Research Center | Los Angeles | California | 90059 | — |
| Anthony Mills, MD, Inc. | Los Angeles | California | 90069 | — |
| AIDS Healthcare Foundation | Los Angeles | California | 90211 | — |
| Palmtree Clinical Research Inc. | Palm Springs | California | 92262 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Kaiser Foundation Research Institute | San Francisco | California | 94118 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| Circle Care Center, LLC | Norwalk | Connecticut | 06850 | — |
| Georgetown University School of Medicine | Washington D.C. | District of Columbia | 20007 | — |
| Gary Richmond, MD, PA | Fort Lauderdale | Florida | 33316 | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | 34982 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Triple O Research Institute | West Palm Beach | Florida | 33401 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30312 | — |
| University of Maryland, Institute of Human Virology | Baltimore | Maryland | 21201 | — |
| Henry Ford Health Systems | Detroit | Michigan | 48202 | — |
| St. John Hospital and Medical Center | Southfield | Michigan | 48075 | — |
| ACRIA | New York | New York | 10018 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Carolinas HealthCare System | Charlotte | North Carolina | 28232 | — |
| North Texas Infectious Disease Consultants | Dallas | Texas | 75246 | — |
| Research Access Network | Houston | Texas | 77098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02475629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02475629 live on ClinicalTrials.gov.